 | • レポートコード：QFJ1-3805 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、貧血治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（サプリメント、抗生物質、免疫抑制剤、骨髄刺激剤、コルチコステロイド、遺伝子治療、鉄キレート剤）、用途別市場規模（鉄欠乏性貧血、サラセミア、再生不良性貧血、溶血性貧血、鎌状赤血球貧血、悪性貧血）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・貧血治療薬の市場動向 ・企業の競争状況、市場シェア ・貧血治療薬の種類別市場規模と予測2016-2027（サプリメント、抗生物質、免疫抑制剤、骨髄刺激剤、コルチコステロイド、遺伝子治療、鉄キレート剤） ・貧血治療薬の用途別市場規模と予測2016-2027（鉄欠乏性貧血、サラセミア、再生不良性貧血、溶血性貧血、鎌状赤血球貧血、悪性貧血） ・貧血治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・貧血治療薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・貧血治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・貧血治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・貧血治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Pfizer, Inc.、Amgen, Inc.、Hoffmann-La Roche Ltd.、Merck Sharp & Dohme Corp.、Novartis AG、Janssen Pharmaceutical、Bayer AG、AMAG Pharmaceuticals、GlaxoSmithKline plc、Akebia Therapeutics、Vifor Pharma Management, Ltd.、FibroGen, Inc.） ・結論 |
Anemia is a condition in which you don’t have enough healthy red blood cells to carry adequate oxygen to the body’s tissues.
Market Analysis and Insights: Global Anemia Treatment Drugs Market
The global Anemia Treatment Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Anemia Treatment Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Anemia Treatment Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Anemia Treatment Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Anemia Treatment Drugs market.
Global Anemia Treatment Drugs Scope and Market Size
Anemia Treatment Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Anemia Treatment Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Supplements
Antibiotics
Immunosuppressant
Bone Marrow Stimulants
Corticosteroids
Gene Therapy
Iron Chelating Agents
Segment by Application
Iron deficiency anemia
Thalassemia
Aplastic anemia
Hemolytic anemia
Sickle cell anemia
Pernicious anemia
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Pfizer, Inc.
Amgen, Inc.
Hoffmann-La Roche Ltd.
Merck Sharp & Dohme Corp.
Novartis AG
Janssen Pharmaceutical
Bayer AG
AMAG Pharmaceuticals
GlaxoSmithKline plc
Akebia Therapeutics
Vifor Pharma Management, Ltd.
FibroGen, Inc.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Anemia Treatment Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Supplements
1.2.3 Antibiotics
1.2.4 Immunosuppressant
1.2.5 Bone Marrow Stimulants
1.2.6 Corticosteroids
1.2.7 Gene Therapy
1.2.8 Iron Chelating Agents
1.3 Market by Application
1.3.1 Global Anemia Treatment Drugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Iron deficiency anemia
1.3.3 Thalassemia
1.3.4 Aplastic anemia
1.3.5 Hemolytic anemia
1.3.6 Sickle cell anemia
1.3.7 Pernicious anemia
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Anemia Treatment Drugs Market Perspective (2016-2027)
2.2 Anemia Treatment Drugs Growth Trends by Regions
2.2.1 Anemia Treatment Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Anemia Treatment Drugs Historic Market Share by Regions (2016-2021)
2.2.3 Anemia Treatment Drugs Forecasted Market Size by Regions (2022-2027)
2.3 Anemia Treatment Drugs Industry Dynamic
2.3.1 Anemia Treatment Drugs Market Trends
2.3.2 Anemia Treatment Drugs Market Drivers
2.3.3 Anemia Treatment Drugs Market Challenges
2.3.4 Anemia Treatment Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Anemia Treatment Drugs Players by Revenue
3.1.1 Global Top Anemia Treatment Drugs Players by Revenue (2016-2021)
3.1.2 Global Anemia Treatment Drugs Revenue Market Share by Players (2016-2021)
3.2 Global Anemia Treatment Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Anemia Treatment Drugs Revenue
3.4 Global Anemia Treatment Drugs Market Concentration Ratio
3.4.1 Global Anemia Treatment Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Anemia Treatment Drugs Revenue in 2020
3.5 Anemia Treatment Drugs Key Players Head office and Area Served
3.6 Key Players Anemia Treatment Drugs Product Solution and Service
3.7 Date of Enter into Anemia Treatment Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Anemia Treatment Drugs Breakdown Data by Type
4.1 Global Anemia Treatment Drugs Historic Market Size by Type (2016-2021)
4.2 Global Anemia Treatment Drugs Forecasted Market Size by Type (2022-2027)
5 Anemia Treatment Drugs Breakdown Data by Application
5.1 Global Anemia Treatment Drugs Historic Market Size by Application (2016-2021)
5.2 Global Anemia Treatment Drugs Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Anemia Treatment Drugs Market Size (2016-2027)
6.2 North America Anemia Treatment Drugs Market Size by Type
6.2.1 North America Anemia Treatment Drugs Market Size by Type (2016-2021)
6.2.2 North America Anemia Treatment Drugs Market Size by Type (2022-2027)
6.2.3 North America Anemia Treatment Drugs Market Size by Type (2016-2027)
6.3 North America Anemia Treatment Drugs Market Size by Application
6.3.1 North America Anemia Treatment Drugs Market Size by Application (2016-2021)
6.3.2 North America Anemia Treatment Drugs Market Size by Application (2022-2027)
6.3.3 North America Anemia Treatment Drugs Market Size by Application (2016-2027)
6.4 North America Anemia Treatment Drugs Market Size by Country
6.4.1 North America Anemia Treatment Drugs Market Size by Country (2016-2021)
6.4.2 North America Anemia Treatment Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Anemia Treatment Drugs Market Size (2016-2027)
7.2 Europe Anemia Treatment Drugs Market Size by Type
7.2.1 Europe Anemia Treatment Drugs Market Size by Type (2016-2021)
7.2.2 Europe Anemia Treatment Drugs Market Size by Type (2022-2027)
7.2.3 Europe Anemia Treatment Drugs Market Size by Type (2016-2027)
7.3 Europe Anemia Treatment Drugs Market Size by Application
7.3.1 Europe Anemia Treatment Drugs Market Size by Application (2016-2021)
7.3.2 Europe Anemia Treatment Drugs Market Size by Application (2022-2027)
7.3.3 Europe Anemia Treatment Drugs Market Size by Application (2016-2027)
7.4 Europe Anemia Treatment Drugs Market Size by Country
7.4.1 Europe Anemia Treatment Drugs Market Size by Country (2016-2021)
7.4.2 Europe Anemia Treatment Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Anemia Treatment Drugs Market Size (2016-2027)
8.2 Asia-Pacific Anemia Treatment Drugs Market Size by Type
8.2.1 Asia-Pacific Anemia Treatment Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Anemia Treatment Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Anemia Treatment Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific Anemia Treatment Drugs Market Size by Application
8.3.1 Asia-Pacific Anemia Treatment Drugs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Anemia Treatment Drugs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Anemia Treatment Drugs Market Size by Application (2016-2027)
8.4 Asia-Pacific Anemia Treatment Drugs Market Size by Region
8.4.1 Asia-Pacific Anemia Treatment Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Anemia Treatment Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Anemia Treatment Drugs Market Size (2016-2027)
9.2 Latin America Anemia Treatment Drugs Market Size by Type
9.2.1 Latin America Anemia Treatment Drugs Market Size by Type (2016-2021)
9.2.2 Latin America Anemia Treatment Drugs Market Size by Type (2022-2027)
9.2.3 Latin America Anemia Treatment Drugs Market Size by Type (2016-2027)
9.3 Latin America Anemia Treatment Drugs Market Size by Application
9.3.1 Latin America Anemia Treatment Drugs Market Size by Application (2016-2021)
9.3.2 Latin America Anemia Treatment Drugs Market Size by Application (2022-2027)
9.3.3 Latin America Anemia Treatment Drugs Market Size by Application (2016-2027)
9.4 Latin America Anemia Treatment Drugs Market Size by Country
9.4.1 Latin America Anemia Treatment Drugs Market Size by Country (2016-2021)
9.4.2 Latin America Anemia Treatment Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Anemia Treatment Drugs Market Size (2016-2027)
10.2 Middle East & Africa Anemia Treatment Drugs Market Size by Type
10.2.1 Middle East & Africa Anemia Treatment Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Anemia Treatment Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Anemia Treatment Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa Anemia Treatment Drugs Market Size by Application
10.3.1 Middle East & Africa Anemia Treatment Drugs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Anemia Treatment Drugs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Anemia Treatment Drugs Market Size by Application (2016-2027)
10.4 Middle East & Africa Anemia Treatment Drugs Market Size by Country
10.4.1 Middle East & Africa Anemia Treatment Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Anemia Treatment Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Pfizer, Inc.
11.1.1 Pfizer, Inc. Company Details
11.1.2 Pfizer, Inc. Business Overview
11.1.3 Pfizer, Inc. Anemia Treatment Drugs Introduction
11.1.4 Pfizer, Inc. Revenue in Anemia Treatment Drugs Business (2016-2021)
11.1.5 Pfizer, Inc. Recent Development
11.2 Amgen, Inc.
11.2.1 Amgen, Inc. Company Details
11.2.2 Amgen, Inc. Business Overview
11.2.3 Amgen, Inc. Anemia Treatment Drugs Introduction
11.2.4 Amgen, Inc. Revenue in Anemia Treatment Drugs Business (2016-2021)
11.2.5 Amgen, Inc. Recent Development
11.3 Hoffmann-La Roche Ltd.
11.3.1 Hoffmann-La Roche Ltd. Company Details
11.3.2 Hoffmann-La Roche Ltd. Business Overview
11.3.3 Hoffmann-La Roche Ltd. Anemia Treatment Drugs Introduction
11.3.4 Hoffmann-La Roche Ltd. Revenue in Anemia Treatment Drugs Business (2016-2021)
11.3.5 Hoffmann-La Roche Ltd. Recent Development
11.4 Merck Sharp & Dohme Corp.
11.4.1 Merck Sharp & Dohme Corp. Company Details
11.4.2 Merck Sharp & Dohme Corp. Business Overview
11.4.3 Merck Sharp & Dohme Corp. Anemia Treatment Drugs Introduction
11.4.4 Merck Sharp & Dohme Corp. Revenue in Anemia Treatment Drugs Business (2016-2021)
11.4.5 Merck Sharp & Dohme Corp. Recent Development
11.5 Novartis AG
11.5.1 Novartis AG Company Details
11.5.2 Novartis AG Business Overview
11.5.3 Novartis AG Anemia Treatment Drugs Introduction
11.5.4 Novartis AG Revenue in Anemia Treatment Drugs Business (2016-2021)
11.5.5 Novartis AG Recent Development
11.6 Janssen Pharmaceutical
11.6.1 Janssen Pharmaceutical Company Details
11.6.2 Janssen Pharmaceutical Business Overview
11.6.3 Janssen Pharmaceutical Anemia Treatment Drugs Introduction
11.6.4 Janssen Pharmaceutical Revenue in Anemia Treatment Drugs Business (2016-2021)
11.6.5 Janssen Pharmaceutical Recent Development
11.7 Bayer AG
11.7.1 Bayer AG Company Details
11.7.2 Bayer AG Business Overview
11.7.3 Bayer AG Anemia Treatment Drugs Introduction
11.7.4 Bayer AG Revenue in Anemia Treatment Drugs Business (2016-2021)
11.7.5 Bayer AG Recent Development
11.8 AMAG Pharmaceuticals
11.8.1 AMAG Pharmaceuticals Company Details
11.8.2 AMAG Pharmaceuticals Business Overview
11.8.3 AMAG Pharmaceuticals Anemia Treatment Drugs Introduction
11.8.4 AMAG Pharmaceuticals Revenue in Anemia Treatment Drugs Business (2016-2021)
11.8.5 AMAG Pharmaceuticals Recent Development
11.9 GlaxoSmithKline plc
11.9.1 GlaxoSmithKline plc Company Details
11.9.2 GlaxoSmithKline plc Business Overview
11.9.3 GlaxoSmithKline plc Anemia Treatment Drugs Introduction
11.9.4 GlaxoSmithKline plc Revenue in Anemia Treatment Drugs Business (2016-2021)
11.9.5 GlaxoSmithKline plc Recent Development
11.10 Akebia Therapeutics
11.10.1 Akebia Therapeutics Company Details
11.10.2 Akebia Therapeutics Business Overview
11.10.3 Akebia Therapeutics Anemia Treatment Drugs Introduction
11.10.4 Akebia Therapeutics Revenue in Anemia Treatment Drugs Business (2016-2021)
11.10.5 Akebia Therapeutics Recent Development
11.11 Vifor Pharma Management, Ltd.
11.11.1 Vifor Pharma Management, Ltd. Company Details
11.11.2 Vifor Pharma Management, Ltd. Business Overview
11.11.3 Vifor Pharma Management, Ltd. Anemia Treatment Drugs Introduction
11.11.4 Vifor Pharma Management, Ltd. Revenue in Anemia Treatment Drugs Business (2016-2021)
11.11.5 Vifor Pharma Management, Ltd. Recent Development
11.12 FibroGen, Inc.
11.12.1 FibroGen, Inc. Company Details
11.12.2 FibroGen, Inc. Business Overview
11.12.3 FibroGen, Inc. Anemia Treatment Drugs Introduction
11.12.4 FibroGen, Inc. Revenue in Anemia Treatment Drugs Business (2016-2021)
11.12.5 FibroGen, Inc. Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Anemia Treatment Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Supplements
Table 3. Key Players of Antibiotics
Table 4. Key Players of Immunosuppressant
Table 5. Key Players of Bone Marrow Stimulants
Table 6. Key Players of Corticosteroids
Table 7. Key Players of Gene Therapy
Table 8. Key Players of Iron Chelating Agents
Table 9. Global Anemia Treatment Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Anemia Treatment Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 11. Global Anemia Treatment Drugs Market Size by Regions (2016-2021) & (US$ Million)
Table 12. Global Anemia Treatment Drugs Market Share by Regions (2016-2021)
Table 13. Global Anemia Treatment Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 14. Global Anemia Treatment Drugs Market Share by Regions (2022-2027)
Table 15. Anemia Treatment Drugs Market Trends
Table 16. Anemia Treatment Drugs Market Drivers
Table 17. Anemia Treatment Drugs Market Challenges
Table 18. Anemia Treatment Drugs Market Restraints
Table 19. Global Anemia Treatment Drugs Revenue by Players (2016-2021) & (US$ Million)
Table 20. Global Anemia Treatment Drugs Market Share by Players (2016-2021)
Table 21. Global Top Anemia Treatment Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anemia Treatment Drugs as of 2020)
Table 22. Ranking of Global Top Anemia Treatment Drugs Companies by Revenue (US$ Million) in 2020
Table 23. Global 5 Largest Players Market Share by Anemia Treatment Drugs Revenue (CR5 and HHI) & (2016-2021)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Anemia Treatment Drugs Product Solution and Service
Table 26. Date of Enter into Anemia Treatment Drugs Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Anemia Treatment Drugs Market Size by Type (2016-2021) (US$ Million)
Table 29. Global Anemia Treatment Drugs Revenue Market Share by Type (2016-2021)
Table 30. Global Anemia Treatment Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 31. Global Anemia Treatment Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 32. Global Anemia Treatment Drugs Market Size Share by Application (2016-2021) & (US$ Million)
Table 33. Global Anemia Treatment Drugs Revenue Market Share by Application (2016-2021)
Table 34. Global Anemia Treatment Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 35. Global Anemia Treatment Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 36. North America Anemia Treatment Drugs Market Size by Type (2016-2021) (US$ Million)
Table 37. North America Anemia Treatment Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 38. North America Anemia Treatment Drugs Market Size by Application (2016-2021) (US$ Million)
Table 39. North America Anemia Treatment Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 40. North America Anemia Treatment Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 41. North America Anemia Treatment Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 42. Europe Anemia Treatment Drugs Market Size by Type (2016-2021) (US$ Million)
Table 43. Europe Anemia Treatment Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 44. Europe Anemia Treatment Drugs Market Size by Application (2016-2021) (US$ Million)
Table 45. Europe Anemia Treatment Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 46. Europe Anemia Treatment Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 47. Europe Anemia Treatment Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Anemia Treatment Drugs Market Size by Type (2016-2021) (US$ Million)
Table 49. Asia-Pacific Anemia Treatment Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Anemia Treatment Drugs Market Size by Application (2016-2021) (US$ Million)
Table 51. Asia-Pacific Anemia Treatment Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 52. Asia-Pacific Anemia Treatment Drugs Market Size by Region (2016-2021) & (US$ Million)
Table 53. Asia-Pacific Anemia Treatment Drugs Market Size by Region (2022-2027) & (US$ Million)
Table 54. Latin America Anemia Treatment Drugs Market Size by Type (2016-2021) (US$ Million)
Table 55. Latin America Anemia Treatment Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 56. Latin America Anemia Treatment Drugs Market Size by Application (2016-2021) (US$ Million)
Table 57. Latin America Anemia Treatment Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 58. Latin America Anemia Treatment Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 59. Latin America Anemia Treatment Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Anemia Treatment Drugs Market Size by Type (2016-2021) (US$ Million)
Table 61. Middle East & Africa Anemia Treatment Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Anemia Treatment Drugs Market Size by Application (2016-2021) (US$ Million)
Table 63. Middle East & Africa Anemia Treatment Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 64. Middle East & Africa Anemia Treatment Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 65. Middle East & Africa Anemia Treatment Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 66. Pfizer, Inc. Company Details
Table 67. Pfizer, Inc. Business Overview
Table 68. Pfizer, Inc. Anemia Treatment Drugs Product
Table 69. Pfizer, Inc. Revenue in Anemia Treatment Drugs Business (2016-2021) & (US$ Million)
Table 70. Pfizer, Inc. Recent Development
Table 71. Amgen, Inc. Company Details
Table 72. Amgen, Inc. Business Overview
Table 73. Amgen, Inc. Anemia Treatment Drugs Product
Table 74. Amgen, Inc. Revenue in Anemia Treatment Drugs Business (2016-2021) & (US$ Million)
Table 75. Amgen, Inc. Recent Development
Table 76. Hoffmann-La Roche Ltd. Company Details
Table 77. Hoffmann-La Roche Ltd. Business Overview
Table 78. Hoffmann-La Roche Ltd. Anemia Treatment Drugs Product
Table 79. Hoffmann-La Roche Ltd. Revenue in Anemia Treatment Drugs Business (2016-2021) & (US$ Million)
Table 80. Hoffmann-La Roche Ltd. Recent Development
Table 81. Merck Sharp & Dohme Corp. Company Details
Table 82. Merck Sharp & Dohme Corp. Business Overview
Table 83. Merck Sharp & Dohme Corp. Anemia Treatment Drugs Product
Table 84. Merck Sharp & Dohme Corp. Revenue in Anemia Treatment Drugs Business (2016-2021) & (US$ Million)
Table 85. Merck Sharp & Dohme Corp. Recent Development
Table 86. Novartis AG Company Details
Table 87. Novartis AG Business Overview
Table 88. Novartis AG Anemia Treatment Drugs Product
Table 89. Novartis AG Revenue in Anemia Treatment Drugs Business (2016-2021) & (US$ Million)
Table 90. Novartis AG Recent Development
Table 91. Janssen Pharmaceutical Company Details
Table 92. Janssen Pharmaceutical Business Overview
Table 93. Janssen Pharmaceutical Anemia Treatment Drugs Product
Table 94. Janssen Pharmaceutical Revenue in Anemia Treatment Drugs Business (2016-2021) & (US$ Million)
Table 95. Janssen Pharmaceutical Recent Development
Table 96. Bayer AG Company Details
Table 97. Bayer AG Business Overview
Table 98. Bayer AG Anemia Treatment Drugs Product
Table 99. Bayer AG Revenue in Anemia Treatment Drugs Business (2016-2021) & (US$ Million)
Table 100. Bayer AG Recent Development
Table 101. AMAG Pharmaceuticals Company Details
Table 102. AMAG Pharmaceuticals Business Overview
Table 103. AMAG Pharmaceuticals Revenue in Anemia Treatment Drugs Business (2016-2021) & (US$ Million)
Table 104. AMAG Pharmaceuticals Recent Development
Table 105. GlaxoSmithKline plc Company Details
Table 106. GlaxoSmithKline plc Business Overview
Table 107. GlaxoSmithKline plc Anemia Treatment Drugs Product
Table 108. GlaxoSmithKline plc Revenue in Anemia Treatment Drugs Business (2016-2021) & (US$ Million)
Table 109. GlaxoSmithKline plc Recent Development
Table 110. Akebia Therapeutics Company Details
Table 111. Akebia Therapeutics Business Overview
Table 112. Akebia Therapeutics Anemia Treatment Drugs Product
Table 113. Akebia Therapeutics Revenue in Anemia Treatment Drugs Business (2016-2021) & (US$ Million)
Table 114. Akebia Therapeutics Recent Development
Table 115. Vifor Pharma Management, Ltd. Company Details
Table 116. Vifor Pharma Management, Ltd. Business Overview
Table 117. Vifor Pharma Management, Ltd. Anemia Treatment Drugs Product
Table 118. Vifor Pharma Management, Ltd. Revenue in Anemia Treatment Drugs Business (2016-2021) & (US$ Million)
Table 119. Vifor Pharma Management, Ltd. Recent Development
Table 120. FibroGen, Inc. Company Details
Table 121. FibroGen, Inc. Business Overview
Table 122. FibroGen, Inc. Anemia Treatment Drugs Product
Table 123. FibroGen, Inc. Revenue in Anemia Treatment Drugs Business (2016-2021) & (US$ Million)
Table 124. FibroGen, Inc. Recent Development
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Anemia Treatment Drugs Market Share by Type: 2020 VS 2027
Figure 2. Supplements Features
Figure 3. Antibiotics Features
Figure 4. Immunosuppressant Features
Figure 5. Bone Marrow Stimulants Features
Figure 6. Corticosteroids Features
Figure 7. Gene Therapy Features
Figure 8. Iron Chelating Agents Features
Figure 9. Global Anemia Treatment Drugs Market Share by Application: 2020 VS 2027
Figure 10. Iron deficiency anemia Case Studies
Figure 11. Thalassemia Case Studies
Figure 12. Aplastic anemia Case Studies
Figure 13. Hemolytic anemia Case Studies
Figure 14. Sickle cell anemia Case Studies
Figure 15. Pernicious anemia Case Studies
Figure 16. Anemia Treatment Drugs Report Years Considered
Figure 17. Global Anemia Treatment Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 18. Global Anemia Treatment Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 19. Global Anemia Treatment Drugs Market Share by Regions: 2020 VS 2027
Figure 20. Global Anemia Treatment Drugs Market Share by Regions (2022-2027)
Figure 21. Global Anemia Treatment Drugs Market Share by Players in 2020
Figure 22. Global Top Anemia Treatment Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anemia Treatment Drugs as of 2020
Figure 23. The Top 10 and 5 Players Market Share by Anemia Treatment Drugs Revenue in 2020
Figure 24. Global Anemia Treatment Drugs Revenue Market Share by Type (2016-2021)
Figure 25. Global Anemia Treatment Drugs Revenue Market Share by Type (2022-2027)
Figure 26. North America Anemia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. North America Anemia Treatment Drugs Market Share by Type (2016-2027)
Figure 28. North America Anemia Treatment Drugs Market Share by Application (2016-2027)
Figure 29. North America Anemia Treatment Drugs Market Share by Country (2016-2027)
Figure 30. United States Anemia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Canada Anemia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Europe Anemia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Europe Anemia Treatment Drugs Market Share by Type (2016-2027)
Figure 34. Europe Anemia Treatment Drugs Market Share by Application (2016-2027)
Figure 35. Europe Anemia Treatment Drugs Market Share by Country (2016-2027)
Figure 36. Germany Anemia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. France Anemia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. U.K. Anemia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Italy Anemia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Russia Anemia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Nordic Anemia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Asia-Pacific Anemia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Asia-Pacific Anemia Treatment Drugs Market Share by Type (2016-2027)
Figure 44. Asia-Pacific Anemia Treatment Drugs Market Share by Application (2016-2027)
Figure 45. Asia-Pacific Anemia Treatment Drugs Market Share by Region (2016-2027)
Figure 46. China Anemia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Japan Anemia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. South Korea Anemia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Southeast Asia Anemia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. India Anemia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Australia Anemia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Latin America Anemia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Latin America Anemia Treatment Drugs Market Share by Type (2016-2027)
Figure 54. Latin America Anemia Treatment Drugs Market Share by Application (2016-2027)
Figure 55. Latin America Anemia Treatment Drugs Market Share by Country (2016-2027)
Figure 56. Mexico Anemia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Brazil Anemia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Middle East & Africa Anemia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Middle East & Africa Anemia Treatment Drugs Market Share by Type (2016-2027)
Figure 60. Middle East & Africa Anemia Treatment Drugs Market Share by Application (2016-2027)
Figure 61. Middle East & Africa Anemia Treatment Drugs Market Share by Country (2016-2027)
Figure 62. Turkey Anemia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 63. Saudi Arabia Anemia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 64. UAE Anemia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 65. Pfizer, Inc. Revenue Growth Rate in Anemia Treatment Drugs Business (2016-2021)
Figure 66. Amgen, Inc. Revenue Growth Rate in Anemia Treatment Drugs Business (2016-2021)
Figure 67. Hoffmann-La Roche Ltd. Revenue Growth Rate in Anemia Treatment Drugs Business (2016-2021)
Figure 68. Merck Sharp & Dohme Corp. Revenue Growth Rate in Anemia Treatment Drugs Business (2016-2021)
Figure 69. Novartis AG Revenue Growth Rate in Anemia Treatment Drugs Business (2016-2021)
Figure 70. Janssen Pharmaceutical Revenue Growth Rate in Anemia Treatment Drugs Business (2016-2021)
Figure 71. Bayer AG Revenue Growth Rate in Anemia Treatment Drugs Business (2016-2021)
Figure 72. AMAG Pharmaceuticals Revenue Growth Rate in Anemia Treatment Drugs Business (2016-2021)
Figure 73. GlaxoSmithKline plc Revenue Growth Rate in Anemia Treatment Drugs Business (2016-2021)
Figure 74. Akebia Therapeutics Revenue Growth Rate in Anemia Treatment Drugs Business (2016-2021)
Figure 75. Vifor Pharma Management, Ltd. Revenue Growth Rate in Anemia Treatment Drugs Business (2016-2021)
Figure 76. FibroGen, Inc. Revenue Growth Rate in Anemia Treatment Drugs Business (2016-2021)
Figure 77. Bottom-up and Top-down Approaches for This Report
Figure 78. Data Triangulation
Figure 79. Key Executives Interviewed
世界の鉄欠乏性貧血治療薬市場規模・現状・予測（2021年-2027年） Iron deficiency anemia is a decrease in the red cells of the blood caused by too little iron.The most economical and effective medical treatment for iron deficiency anemia is the oral administration of ferrous iron salts. Market Analysis and Insights: Global Iron Deficiency Anemia Drug Market The gl…- 世界の鎌状赤血球貧血検査＆スクリーニング市場規模・現状・予測（2021年-2027年） Sickle Cell Disease, an inherited blood disorder, often causes red blood cells (RBCs) to become sickle-shaped through the presence of the abnormal hemoglobin S variant. Highly rigid sickle-shaped blood may have difficulty passing through small blood vessels, blocking the normal blood flow, damaging …
- 世界の自己免疫性溶血性貧血治療薬市場規模・現状・予測（2021年-2027年） Autoimmune Hemolytic Anemia (AHA) is also called immune hemolytic anemia. It is an immune and rare red blood cell disorder. Autoimmune hemolytic anemia occurs when the immune system makes antibodies that attack red blood cells in the body. This decreases the number of red blood cells, resulting to h…
- ファンコニ貧血薬のグローバル市場調査 2019年 The global Fanconi Anemia Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Fanconi Anemia Drug volume and value at global level, regional level and company level. From a global perspective, this…
- 世界の血液＆骨髄腫治療市場規模・現状・予測（2021年-2027年） Blood cancer begins in the bone marrow which is the integral source of stem cells which later are differentiated in different types of blood cells in the human body. Market Analysis and Insights: Global Blood and Bone Marrow Cancer Treatment Market The global Blood and Bone Marrow Cancer Treatment m…